Global Self-Injections Market 2024 - Business Opportunities, Industry Growth, Regional Analysis And Forecast To 2033

The new report published by The Business Research Company, titled ""Self-Injections Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the self-injections market size has grown exponentially in recent years. It will grow from $50.72 billion in 2023 to $63.54 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The self-injections market size is expected to see exponential growth in the next few years. It will grow to $147.24 billion in 2028 at a compound annual growth rate (CAGR) of 23.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp

Surging Diabetic Cases Fueling Growth In The Self-Injections Market
The growing number of diabetic patients is expected to propel the growth of the self-injections market going forward. Diabetes refers to a condition where the pancreas, a human organ that produces insulin, produce less than an adequate level of insulin which leads to the breakdown of blood sugars and causes serious health conditions like heart disease, vision loss, and kidney diseases. Self-injections can be used by diabetic patients for injecting insulin and other medications which help maintain optimum blood sugar levels and block any excess blood sugars at any given point of time without the help of a medical professional. For instance, according to International Diabetes Federation (IDF), a Belgium-based organization that represents 230 national diabetes associations in more than 160 countries and territories, in 2021, 567 million adults aged between 20 to 79 years are currently living with diabetes, and the number of diabetic patients is expected to grow and reach 643 million by 2030 and 783 million by 2045. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.

Product Innovations Transforming The Self Injections Market
Major companies operating in the self injections market are developing new solutions for insulin injections to gain a competitive edge in the market. For instance, in September 2022, Terumo Corporation, a Japan-based medical device company launched FineGlide, a Sterile Pen Needle designed for patients requiring regular insulin injections or other self-medication. Compatible with most commonly used pen devices in India, FineGlide prioritizes patient comfort, aiming to enhance drug compliance. FineGlide boasts a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness and comfort for patients. It incorporates Thin Wall Technology for improved flow rate and reduced injection force.

The self-injections market covered in this report is segmented -

1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=8235&type=discount

Major companies operating in the self-injections market report are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, Scintilla Pharmaceuticals Inc., SHL Group.Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

Contents of the report:
1. Executive Summary
2. Self-Injections Market Report Structure
3. Self-Injections Market Trends And Strategies
4. Self-Injections Market - Macro Economic Scenario
5. Self-Injections Market Size And Growth
…..
27. Self-Injections Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.